Pathological characteristics of BRCA -associated breast cancers in Hispanics

By Lagos-Jaramillo Veronica  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 281-289

Springer Publishing Company

Access to resources Recommend Favorite

Familial breast and ovarian cancers

By Arai Masami   Utsunomiya Joji   Miki Yoshio  

International Journal of Clinical Oncology, Vol. 9, Iss. 4, 2004-08 ,pp. : 270-282

Springer Publishing Company

Access to resources Recommend Favorite

PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers

By Stebbing Justin   Ellis Paul   Tutt Andrew  

Future Oncology, Vol. 6, Iss. 4, 2010-04 ,pp. : 485-486

Future Medicine

Access to resources Recommend Favorite

Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor α and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts

By Bouclier Céline   Marsaud Véronique   Bawa Olivia   Nicolas Valérie   Moine Laurence   Opolon Paule   Renoir Jack-Michel  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 145-158

Springer Publishing Company

Access to resources Recommend Favorite

Anti-oestrogen Stimulation of ERBB2 Ectodomain Shedding from BT-474 Human Breast Cancer Cells with ERBB2 Gene Amplification

By Warri A.M.   Isola J.J.   Harkonen P.L.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 134-140

Elsevier

Access to resources Recommend Favorite